Valvular lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome: An old disease but a persistent challenge

Libman, 1924, A hitherto undescribed form of valvular and mural endocarditis, Arch Intern Med, 33, 701, 10.1001/archinte.1924.00110300044002 Doherty, 1985, Cardiovascular manifestations of systemic lupus erythematosus, Am Heart J, 110, 1257, 10.1016/0002-8703(85)90023-7 Ansari, 1985, Cardiovascular manifestations of systemic lupus erythematosus: current perspective, Prog Cardiovasc Dis, 27, 421, 10.1016/0033-0620(85)90003-9 D’Alton, 1985, Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis, Stroke, 16, 512, 10.1161/01.STR.16.3.512 Hughes, 1983, Thrombosis, abortion, cerebral disease and the lupus anticoagulant, Br Med J, 287, 1088, 10.1136/bmj.287.6399.1088 Hughes, 1986, The anticardiolipin syndrome, J Rheumatol, 13, 486 Harris, 1990, A reassessment of the antiphospholipid syndrome, J Rheumatol, 17, 733 Levine, 2002, The antiphospholipid syndrome, N Engl J Med, 346, 752, 10.1056/NEJMra002974 Wilson, 1999, International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop, Arthritis Rheum, 42, 1309, 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F Brigden, 1960, The heart in systemic lupus erythematosus, Br Heart J, 22, 1, 10.1136/hrt.22.1.1 Farzaneh-far, 2006, Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus, Arthritis Rheum, 54, 3918, 10.1002/art.22265 Straaton, 1989, Clinically significant valvular heart disease in systemic lupus erythematosus, Am J Med, 86, 407 Galve, 1988, Prevalence, morphologic types and evolution of cardiac valvular disease in systemic lupus erythematosus, N Engl J Med, 319, 817, 10.1056/NEJM198809293191302 Nihoyannopoulos, 1990, Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies, Circulation, 82, 369, 10.1161/01.CIR.82.2.369 Khamashta, 1990, Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus, Lancet, 335, 1541, 10.1016/0140-6736(90)91373-I Cervera, 1992, Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients, Ann Rheum Dis, 51, 156, 10.1136/ard.51.2.156 Jouhikainen, 1994, Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus, Lupus, 3, 167, 10.1177/096120339400300307 Vianna, 1994, Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients, Am J Med, 96, 3, 10.1016/0002-9343(94)90108-2 Roldan, 1992, Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies, J Am Coll Cardiol, 20, 1127, 10.1016/0735-1097(92)90368-W Perez-Villa, 2005, Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, follow-up study, Arthritis Rheum (Arthritis Care Res), 53, 460, 10.1002/art.21162 Moyssakis, 2007, Libman–Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution, Am J Med, 120, 636, 10.1016/j.amjmed.2007.01.024 Hojnik, 1996, Heart valve involvement (Libman–Sacks endocarditis) in the antiphospholipid syndrome, Circulation, 93, 1579, 10.1161/01.CIR.93.8.1579 Ford, 1990, A possible role for antiphospholipid antibodies in acquired cardiac valve deformity, J Rheumatol, 17, 1499 Ziporen, 1996, Libman–Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves, Lupus, 5, 196, 10.1177/096120339600500306 Asherson, 1989, The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies, Clin Exp Rheumatol, 7, 225 Roberts, 1999, The heart in systemic lupus erythematosus, Curr Probl Cardiol, 24, 1, 10.1016/S0146-2806(99)90019-1 Roldan, 1998, Valvular disease associated with systemic illness, Cardiol Clin, 16, 531, 10.1016/S0733-8651(05)70030-8 Li, 2000, Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clin Infect Dis, 30, 633, 10.1086/313753 Menard, 2008, Establishing the diagnosis of Libman–Sacks endocarditis in systemic lupus erythematosus, J Gen Intern Med, 23, 883, 10.1007/s11606-008-0627-8 Lee, 2009, Revisiting Libman–Sacks endocarditis: a historical review and update, Clin Rev Allergy Immunol, 36, 126, 10.1007/s12016-008-8113-y Asherson, 1991, Antiphospholipid antibodies and the heart, Circulation, 84, 920, 10.1161/01.CIR.84.2.920 Mottram, 2002, Mitral valve thrombus mimicking a primary tumor in the antiphospholipid syndrome, J Am Soc Echocardiogr, 15, 746, 10.1067/mje.2002.118914 Taguchi, 2006, A case of mitral valve plasty for Libman–Sacks endocarditis mimicking a cardiac tumor, J Thorac Cardiovasc Surg, 132, 1465, 10.1016/j.jtcvs.2006.07.034 Appelbe, 1991, Libman–Sacks endocarditis mimicking intracardiac tumor, Am J Cardiol, 68, 817, 10.1016/0002-9149(91)90666-9 Bouma, 2010, Mitral valve surgery for mitral regurgitation caused by Libman–Sacks endocarditis: a report of four cases and a systematic review of the literature, J Cardiothorac Surg, 5, 13, 10.1186/1749-8090-5-13 Lopez, 1987, Echocardiographic features of nonbacterial thrombotic endocarditis, Am J Cardiol, 59, 478, 10.1016/0002-9149(87)90961-1 Roldan, 2008, Transthoracic versus transesophageal echocardiography for detection of Libman–Sacks endocarditis: a randomized controlled study, J Rheumatol, 35, 224 Feigenbaum, 2005 Morin, 1996, Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature, Thorac Cardiovasc Surg, 44, 313, 10.1055/s-2007-1012045 Bulkey, 1975, Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease, Am J Cardiol, 35, 305, 10.1016/0002-9149(75)90018-1 Colli, 2010, Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases, Eur J Cardiothorac Surg, 37, 154, 10.1016/j.ejcts.2009.06.046 Roldan, 1996, An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus, N Engl J Med, 335, 1424, 10.1056/NEJM199611073351903 Nesher, 1997, Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment, Semin Arthritis Rheum, 27, 27, 10.1016/S0049-0172(97)80034-0 Hakim, 2001, Mitral valve replacement and repair. Report of 5 patients with systemic lupus erythematosus, Tex Heart Inst J, 28, 47 Lockhart, 2007, The evidence base for the efficacy of antibiotic prophylaxis in dental practice, JAMA, 138, 458 Dória, 2005, Cardiac involvement in systemic lupus erythematosus, Lupus, 14, 683, 10.1191/0961203305lu2200oa Habib, 2009, Guidelines on the prevention, diagnosis, and treatment of infective endocarditis. New version 2009, Eur Heart J, 30, 2369